Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council. The council consists of people living with Parkinson’s disease and care partners who contribute their personal perspectives and experiences with the disease to ensure that all foundation programs and priorities are based on real-world needs and evidence.

“One of the fundamental ways the Parkinson’s Foundation serves its community is through the People with Parkinson’s Advisory Council,” said John Lehr, Parkinson’s Foundation president and chief executive officer. “We welcome our five new advisors who have the expertise and leadership within their communities to help us make life better for people with Parkinson’s.”

The advisory council’s newest members have a diverse background of professional skills and experiences:

  • Justin Fields, MBA, of Knoxville, TN
    In addition to working full-time, Fields, who is living with young-onset Parkinson’s, strives to expand local Parkinson’s support groups to foster awareness and community outreach.
     
  • Radhika D. Iyer, JD, MSW, of Durham, NC
    Iyer, a social worker, lawyer and health care technologist living with Parkinson’s, previously served as a board member on the Parkinson’s Foundation Western New York. Iyer helps people with Parkinson’s use technology, such as applications, to better manage their symptoms.
     
  • Glenn Kasman, MS, of Mercer Island, WA
    A retired healthcare executive and textbook co-author, Kasman has remained active within his local Parkinson’s support groups and as a peer mentor since his initial Parkinson’s diagnosis in 2015.
     
  • Gretchen Rosswurm, MS, of Irving, TX
    Vice president of philanthropy for Celanese Corporation, Rosswurm is living with Parkinson’s. She blogs and writes short fiction.
     
  • Karen St. Clair, of Santa Fe, NM
    Retired CEO, St. Clair and her husband, Rob St. Clair, who is living with Parkinson’s, started a support group. She is a board member on the New Mexico Parkinson’s Coalition.
     

In addition to the five new PPAC members, as of June 1, the council appointed Kelly Sweeney of Portland, Ore., as the chair, and Leslie Peters of Colorado Springs, Colo., as vice chair.

“The People with Parkinson's Advisory Council provides a vital perspective to the Parkinson's Foundation,” said Kelly Sweeney, PPAC chair. “As people living with Parkinson’s and care partners, our voice is represented, and our needs are understood through PPAC. Our input is aimed at improving quality of life and impacting science to slow or even cure this debilitating disease.”

In 2006, the Parkinson’s Foundation became the first organization to establish a patient leadership group instrumental to establishing programs and research initiatives. A total of 15 PPAC members guide Parkinson’s Foundation priorities, identify unmet needs, provide input on programs, and serve as liaisons to the community.

About the Parkinson’s Foundation 
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease 
Affecting nearly one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression A mood disorder whose symptoms can include a persistent sad or empty mood, feelings of hopelessness or pessimism, irritability and loss of interest or pleasure in previously enjoyable activities. and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

Wednesday, June 13, 2018
Parkinson’s Foundation Announces First Aware in Care Ambassadors
Monday, February 25, 2019

NEW YORK & MIAMI — February 25, 2019 — The Parkinson’s Foundation today announced the first members of its Aware in Care Ambassador Pilot Program, a volunteer group organized to help distribute Aware in Care kits that serve to bolster best practices in treating patients with Parkinson’s disease to both patients and healthcare providers.

Parkinson’s Foundation Hosts Professional Education Training in Iowa City
Wednesday, February 13, 2019

Partnership with the University of Iowa Hospitals & Clinics

Breaking News: Boston Scientific: Boston Scientific Launches Vercise™ Primary Cell And Vercise Gevia™ Deep Brain Stimulation Systems With Directional Leads
Thursday, January 24, 2019

Parkinson's Foundation cited in Boston Scientific Press Release: MARLBOROUGH, Mass., Jan. 24, 2019  -- Boston Scientific Corporation (NYSE: BSX) has launched the Vercise™Primary Cell (PC) and Vercise Gevia™ Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia™ Directional Lead. The new systems, which were recently approved by the U.S.

Parkinson's Foundation Announces State Level Prevalence Medicare Costs of Parkinson's Disease - Diagnosis of Parkinson’s Associated with Greater Spending
Thursday, January 24, 2019


NEW YORK & MIAMI, January 24, 2019—A Parkinson’s Foundation study recently published in the scientific journal, npj Parkinson’s Disease, found that a diagnosis of Parkinson’s disease (PD) was associated with greater healthcare use and spending.

Breaking News: FDA Approves Treatment for “Off” Periods in Parkinson’s
Thursday, December 27, 2018

The U.S. Food and Drug Administration (FDA) has approved INBRIJA™, a levodopa inhalation powder developed by Acorda Therapeutics, as a treatment for “off” periods in people with Parkinson’s disease (PD) who are treated with carbidopa/levodopa.

Quick Facts about INBRIJA™:

Parkinson’s Foundation Hosts Its First-Ever Medical Marijuana and Parkinson’s Disease Conference
Tuesday, December 4, 2018

NEW YORK AND MIAMI— December 4, 2018—The Parkinson’s Foundation will host its first-ever conference focused on medical marijuana and Parkinson’s disease (PD) in Denver, CO, March 6-7, 2019.

Parkinson's Foundation Hosts National Forum for Women Living with Parkinson's Disease
Wednesday, November 7, 2018

MIAMI & NEW YORK — NOVEMBER 7, 2018 —The Parkinson’s Foundation hosted the first national forum for women with Parkinson’s disease (PD) on October 19 at Baylor College of Medicine, a Parkinson’s Foundation Center of Excellence, in Houston, TX.

Parkinson’s Foundation Announces Expansion of Community Grants Program to Address Unmet Community Needs
Thursday, November 1, 2018

NEW YORK & MIAMI — November 1, 2018 — The Parkinson’s Foundation is proud to announce that it is requesting applications for community grants to be awarded nationwide for health, wellness and education programs that address unmet needs in the Parkinson’s disease (PD) community. In 2019, the Parkinson’s Foundation will award $1.2 million in community grants.

Parkinson’s Foundation Hosts Free Bilingual Caregiver Summit
Tuesday, October 30, 2018

MIAMI AND NEW YORK—October 30, 2018—The Parkinson’s Foundation will host a Caregiver Summit – “Cumbre Para Cuidadores” – geared specifically toward caregivers of people living with Parkinson’s disease (PD).

Parkinson’s Foundation Adds James Monhart to its Board of Directors
Monday, October 29, 2018

NEW YORK & MIAMI, October 29, 2018—The Parkinson’s Foundation today announced the election of James F.T. Monhart to its board of directors.

Pages

mail icon

Subscribe here to get the latest news on treatments, research and other updates.